Products - Diabetes | Topic | NICE

Showing 5 products

Sort by Date | Title

Status: Awaiting developmentRemove ‘Status: Awaiting development’ filter

Dexamethasone intravitreal implant for treating diabetic macular oedema in people without a pseudophakic lens [ID3951]
Status:
Awaiting development
Programme:
Technology appraisal guidance
Expected publication date:
14 September 2022
Dulaglutide for treating type 2 diabetes [ID1451]
Status:
Awaiting development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Semaglutide for treating type 2 diabetes (ID1450)
Status:
Awaiting development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Sotagliflozin for treating type 2 diabetes [ID1657]
Status:
Awaiting development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Teplizumab for delaying the onset of type 1 diabetes in people 8 years and over at risk of developing the condition TS ID 10753
Status:
Awaiting development
Programme:
Technology appraisal guidance
Expected publication date:
TBC